Clinical trial
A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer
NCT00779311 is registered in ClinicalTrials.gov with Accelerated Community Oncology Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer
- Lead sponsor
- Accelerated Community Oncology Research Network
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- October 31, 2008
- Completion date
- March 31, 2011
- Enrollment
- 8 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic colorectal cancer